Why is Brawn Biotech falling/rising?

As of 17-Nov, Brawn Biotech Ltd is experiencing a price increase, with its current price at Rs 24.35, reflecting a rise of Rs 1.14 or 4.91%. The stock has shown strong performance today, outperforming its sector by 4.5% and has been on a consecutive gain streak for the last four days, accumulating a total return of 21.39% during this period. It opened with a significant gain of 5% today and reached an intraday high of Rs 24.37. Additionally, Brawn Biotech is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend. However, there has been a notable decline in investor participation, with delivery volume dropping by 66.4% against the 5-day average, which could suggest a potential concern for sustained momentum.
In the broader market context, Brawn Biotech's short-term performance has significantly outpaced the benchmark Sensex, which has only increased by 1.69% over the past week, compared to Brawn Biotech's impressive 15.35% gain. Over the past month, the stock has risen by 21.75%, while the Sensex has only seen a 1.19% increase, further highlighting the stock's strong relative performance. Despite the positive price movements, the falling investor participation may raise questions about the sustainability of this upward trend in the future.